Trials / Recruiting
RecruitingNCT04353557
ctDNA Monitoring in Early Breast Cancer
Monitoring Circulating Tumor DNA in Patients With Early Stage Breast Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Geneplus-Beijing Co. Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a observational, single center study, monitoring the circulating tumor DNA (ctDNA) in patients with early breast cancer and assessing the prognostic value and treatment outcome monitoring of ctDNA.
Conditions
Timeline
- Start date
- 2019-11-29
- Primary completion
- 2025-06-01
- Completion
- 2026-12-01
- First posted
- 2020-04-20
- Last updated
- 2024-07-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04353557. Inclusion in this directory is not an endorsement.